BARCLAYS PLC - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 103 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q1 2019. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q4 2021$62,000
-8.8%
101,986
+55.4%
0.00%
Q3 2021$68,000
-38.7%
65,612
+7.6%
0.00%
Q2 2021$111,000
-11.9%
60,994
-5.0%
0.00%
Q1 2021$126,000
+186.4%
64,217
+160.7%
0.00%
Q3 2020$44,000
-85.6%
24,629
-32.5%
0.00%
Q2 2020$305,000
+510.0%
36,465
+276.2%
0.00%
Q1 2020$50,0009,692
+8874.1%
0.00%
Q4 2019$0
-100.0%
108
-99.7%
0.00%
Q3 2019$179,000
-64.1%
36,705
-49.0%
0.00%
Q2 2019$499,000
+13.4%
71,995
+13.7%
0.00%
Q1 2019$440,000
+746.2%
63,306
+600.2%
0.00%
Q4 2018$52,000
+5100.0%
9,041
+5967.8%
0.00%
Q3 2018$1,000
-98.1%
149
-98.6%
0.00%
Q2 2018$54,000
-68.6%
10,899
-61.5%
0.00%
Q1 2018$172,000
+186.7%
28,302
+237.5%
0.00%
Q4 2017$60,000
-70.0%
8,385
-70.1%
0.00%
Q3 2017$200,000
+163.2%
28,001
+132.7%
0.00%
Q2 2017$76,000
-78.0%
12,031
-71.2%
0.00%
Q1 2017$345,000
-76.5%
41,777
-76.0%
0.00%
-100.0%
Q4 2016$1,470,000173,9870.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q1 2019
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$27,550,00020.34%
AdvisorShares Investments LLC 380,750$2,079,0001.29%
ETF MANAGERS GROUP, LLC 5,779,642$31,557,0001.10%
DAFNA Capital Management LLC 297,300$1,623,0000.56%
GENERAL AMERICAN INVESTORS CO INC 632,400$3,453,0000.32%
Aries Wealth Management 27,900$160,0000.10%
Virtus ETF Advisers LLC 81,751$446,0000.07%
Omnia Family Wealth, LLC 21,726$119,0000.06%
HighVista Strategies LLC 12,200$67,0000.05%
WOODSTOCK CORP 57,213$312,0000.05%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders